Penthrox US's own upcoming catalysts alongside class-defining historical readouts and upcoming primary completion dates in the same mechanism classes. Each event moves the broader thesis for Penthrox US. Showing past 6 months and next 12 months · 3 later hidden.
Same axes, same units. Discontinued and historical pivotal trials excluded; see Competitor Landscape below for the full set.
| Trial | Sponsor | Class | Phase / Line | Design | Primary endpoint | Dosing | Key eligibility | n |
|---|---|---|---|---|---|---|---|---|
| Penthrox US | Medical Developments International | Ion Channel Modulator | Phase 3 | 0 | ||||
| Patient-Titrated Automated Intermittent Boluses of Local Anesthetic vs. a Continuous Infusion Via a Perineural Catheter for Postoperative Analgesia | University of California, San Diego | — |
Read-across commentary attached per trial. Phase ordering preserved within each group.
External analyst notes, journalism, and industry commentary cited with attribution.
"Sponsor guided" dates come from IR materials and earnings calls; hover for the cited source. "CT.gov proxy" dates fall back to the registry primary completion date — actual readouts typically follow by 3-6 months.
| — |
| — |
| — |
| — |
| — |
| Examining Analgesic Synergy and Efficacy in Trauma Care | Wake Forest University Health Sciences | — | Phase 4 | — | — | — | — | — |
| Topical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation | University Health Network, Toronto | — | Phase 4 | — | — | — | — | — |
| Magnesium Infusion for Pain Management in Critically Ill Trauma Patients | University of California, Davis | — | Phase 4 | — | — | — | — | — |
| Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients | Massachusetts General Hospital | — | Phase 4 | — | — | — | — | — |
| Suzetrigine for Acute Pain Control in Patients With Multiple Rib Fractures | University of California, Irvine | — | Phase 4 | — | — | — | — | — |
| Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications | Jay C. Buckey Jr. | — | Phase 4 | — | — | — | — | — |
| Fentanyl or Esketamine for Traumatic PAIN (FORE-PAIN) Trial | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — | Phase 3 | — | — | — | — | — |
| Morphine or Ketamine for Analgesia | Columbia University | — | Phase 3 | — | — | — | — | — |
| Cannabidiol After Multi-Trauma for Pain and Opioid Therapy | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | — | Phase 2 | — | — | — | — | — |
| Sufentanil Versus Ketamine Intranasally in the Management of Severe Acute Trauma-related Pain in Children. | Fondation Lenval | — | Phase 2 | — | — | — | — | — |